2 Programs

  • Second Opinion: Clinical Investigators Provide Perspectives on the Future Role of AKT Inhibition in the Management of Prostate Cancer

    Explore program
  • Second Opinion: Integrating Novel Approaches into the Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer

    Explore program